Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ototoxicity of Artemether/Lumefantrine and Other Antimalarials
NCT00451139Phase 4Completed
- Sponsor
- Jimma University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lumefantrine in malaria (3 arms), sponsored by Jimma University. Primary endpoints: Auditory Brainstem Response at 90 days, Pure-tone Audiometry at 90 days and 1 more. Status: completed.
02
Drugs
lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00451139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451139.